Showing 1 - 2 results of 2 for search 'Kun-Peng Shu', query time: 0.03s Refine Results
  1. 1
    Prior switching to a second-line nonsteroidal antiandrogen does not impact the therapeutic efficacy of abiraterone acetate in patients with metastatic castration-resistant prostate cancer: a real-world retrospective study

    Prior switching to a second-line nonsteroidal antiandrogen does not impact the therapeutic efficacy of abiraterone acetate in patients with metastatic castration-resistant prostate... by Jin-Ge Zhao, Jian-Dong Liu, Peng-Fei Shen, Xin Tang, Guang-Xi Sun, Xing-Ming Zhang, Jun-Ru Chen, Kun-Peng Shu, Ming Shi, Hao Zeng

    Published 2018-01-01
    Get full text
    Article
  2. 2
    Predictive efficacy of the 2014 International Society of Urological Pathology Gleason grading system in initially diagnosed metastatic prostate cancer

    Predictive efficacy of the 2014 International Society of Urological Pathology Gleason grading system in initially diagnosed metastatic prostate cancer by Guang-Xi Sun, Peng-Fei Shen, Xing-Ming Zhang, Jing Gong, Hao-Jun Gui, Kun-Peng Shu, Jiang-Dong Liu, Jinge Zhao, Yao-Jing Yang, Xue-Qin Chen, Ni Chen, Hao Zeng

    Published 2017-01-01
    Get full text
    Article

Search Tools: